Alimera Sciences to Report Second Quarter 2017 Financial Results on August 2nd, 2017
July 24 2017 - 11:00AM
Alimera Sciences (NASDAQ:ALIM), a leader in research, development
and commercialization of prescription ophthalmic pharmaceuticals,
today announced that it will release its financial results for the
second quarter ended June 30, 2017, after the close of the
financial markets on Wednesday, August 2, 2017.
An accompanying conference call will be hosted by Dan Myers,
Chief Executive Officer and Rick Eiswirth, President and Chief
Financial Officer to discuss the results. The call will be held at
9:00 AM ET, on Thursday, August 3, 2017. Please refer to the
information below for conference call dial-in information and
webcast registration.
Conference Details Conference date: Thursday,
August 3, 2017 9:00AM ET Conference dial-in: 877-269-7756
International dial-in: 201-689-7817 Conference Call Name:
Alimera Sciences' Second Quarter 2017 Results Call Webcast
Registration: Click Here Following the live call, a replay
will be available on the Company's website,
www.alimerasciences.com, under "Investor Relations".
About Alimera Sciences Alimera Sciences,
founded in June 2003, is a pharmaceutical company that specializes
in the commercialization and development of prescription ophthalmic
pharmaceuticals. Alimera is presently focused on diseases affecting
the back of the eye, or retina, because these diseases are not well
treated with current therapies and will affect millions of people
in our aging populations. Alimera’s commitment to retina
specialists and their patients is manifest in its product and
development portfolio designed to treat early- and late-stage
diseases. For more information, please visit
www.alimerasciences.com.
Contact
CG CAPITAL
Rich Cockrell
877.889.1972
investorrelations@cg.capital
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Apr 2023 to Apr 2024